Psychiatry and Neurology, Neurology · Porterville, CA
NPI
1841203783
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
4
Medicare group memberships
Hospitals
3
Hospital affiliations
382 North Pearson Drive
Porterville, CA, 93257
Phone (559) 783-0100
Groups this clinician bills Medicare through
Medicare paid, 2024
$392K
5,006 services
Medicare patients, 2024
1,043
Average age 73
Drug cost, 2024
$4.9M
14,451 prescriptions
Company payments, 2025
$1,620
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ramu Thiagarajan was code 99213 (office e&m - established), 1,440 times for 486 patients. In total Ramu Thiagarajan billed 5,006 services in 36 codes, and Medicare paid $392K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-03-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,440 | 486 | $65.00 | $94K |
| 99214 Office E&M - Established | Office | 1,325 | 382 | $91.59 | $121K |
| 99232 Hospital E&M - Subsequent | Facility | 573 | 159 | $61.51 | $35K |
| 95886 Electrical Nerve Conductivity | Office | 249 | 95 | $79.51 | $20K |
| 99223 Hospital E&M - Initial | Facility | 177 | 163 | $135.31 | $24K |
| 99203 Office E&M - New | Office | 137 | 137 | $85.40 | $12K |
| 96372 Injection Administration | Office | 135 | 23 | $10.51 | $1,419 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 129 | 17 | $0.94 | $121 |
| 95913 Electrical Nerve Conductivity | Office | 124 | 95 | $233.44 | $29K |
| 99204 Office E&M - New | Office | 73 | 73 | $124.15 | $9,063 |
| 95816 Neurologic | Office | 65 | 65 | $315.28 | $20K |
| 95977 Electrical Nerve Conductivity | Office | 52 | 12 | $36.04 | $1,874 |
| 95816 Neurologic | Facility | 50 | 49 | $44.49 | $2,225 |
| 95819 Neurologic | Office | 28 | 26 | $383.50 | $11K |
By year: 2022 $457K for 5,559 services; 2023 $422K for 5,621 services; 2024 $392K for 5,006 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ramu Thiagarajan prescribed most often to Medicare patients was Memantine Hcl, with 1,527 prescriptions and refills. In total Ramu Thiagarajan wrote 14,451 Medicare prescriptions that cost $4.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Memantine Hcl Generic | 1,527 | 2,173 | 298 | $30K |
| Gabapentin Generic | 881 | 1,167 | 230 | $11K |
| Levetiracetam Generic | 764 | 1,210 | 149 | $23K |
| Duloxetine Hcl Generic | 754 | 1,100 | 186 | $12K |
| Donepezil Hcl Generic | 733 | 1,456 | 199 | $6,871 |
| Pregabalin Generic | 506 | 614 | 148 | $14K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 436 | 754 | 103 | $7,485 |
| Sertraline Hcl Generic | 433 | 552 | 91 | $1,933 |
| Xcopri Cenobamate | 424 | 443 | 47 | $514K |
| Quetiapine Fumarate Generic | 409 | 474 | 72 | $6,191 |
| Mirtazapine Generic | 384 | 501 | 79 | $3,987 |
| Clonazepam Generic | 289 | 319 | 45 | $1,926 |
| Lacosamide Generic | 244 | 292 | 32 | $17K |
| Divalproex Sodium Generic | 240 | 310 | 34 | $6,890 |
| Primidone Generic | 218 | 297 | 45 | $4,512 |
Brand drugs: 1,629 claims; generic drugs: 12,771 claims; opioid claims: 40.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ramu Thiagarajan $1,620 ($1,620 in general payments such as food, travel and fees) from 14 companies. The largest payer was Abbvie Inc. with $620.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 46 | $620 |
| Vanda Pharmaceuticals Inc. VNDA | 10 | $227 |
| Teva Pharmaceuticals USA, Inc. TEVA | 24 | $163 |
| ACADIA Pharmaceuticals Inc ACAD | 16 | $141 |
| Axsome Therapeutics, Inc. AXSM | 5 | $140 |
| Janssen Biotech, Inc. JNJ | 6 | $140 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 2 | $40.97 |
| SK Life Science, Inc. | 1 | $33.38 |
| Biogen, Inc. BIIB | 2 | $27.78 |
| Octapharma USA, Inc. | 1 | $20.7 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.